MOEXIPRIL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Moexipril Hydrochloride patents expire, and what generic alternatives are available?
Moexipril Hydrochloride is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, Glenmark Pharms, and Heritage. and is included in eight NDAs.
The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MOEXIPRIL HYDROCHLORIDE?
- What are the global sales for MOEXIPRIL HYDROCHLORIDE?
- What is Average Wholesale Price for MOEXIPRIL HYDROCHLORIDE?
Summary for MOEXIPRIL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 6 |
| Patent Applications: | 1,690 |
| DailyMed Link: | MOEXIPRIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MOEXIPRIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Nebraska | Phase 4 |
| Teva Pharmaceuticals USA | Phase 1 |
| UCB Pharma | Phase 2 |
Pharmacology for MOEXIPRIL HYDROCHLORIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for MOEXIPRIL HYDROCHLORIDE
US Patents and Regulatory Information for MOEXIPRIL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | MOEXIPRIL HYDROCHLORIDE | moexipril hydrochloride | TABLET;ORAL | 078454-001 | Jun 2, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 076980-001 | Mar 7, 2007 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | MOEXIPRIL HYDROCHLORIDE | moexipril hydrochloride | TABLET;ORAL | 076204-001 | May 8, 2003 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
